Compounded semaglutide and generic semaglutide are not the same thing. Compounded semaglutide is a custom-made drug prepared by a compounding pharmacy and is not reviewed by the FDA for safety, effectiveness, or quality. Generic semaglutide is a regulator-approved generic version of semaglutide that must meet approval standards in the country where it is authorized.
As of July 1, 2026, Health Canada has approved three generic semaglutide injections, including a generic version of Wegovy.
Is compounded semaglutide the same as generic?
No. The main difference between compounded semaglutide and generic semaglutide is how they are made and reviewed.
Compounded semaglutide is a medication custom-prepared by a compounding pharmacy. It can be appropriate if you have a specific medical need that an approved drug cannot meet, such as an allergy to an inactive ingredient or a need for a special dosage form.
However, compounded medications do not undergo FDA review for safety, effectiveness, quality, and manufacturing consistency.
Generic semaglutide, on the other hand, is a manufactured medication that has been reviewed by a national drug regulator, such as Health Canada. Like other generic drugs, generic semaglutide is designed to match a brand-name drug (Ozempic or Wegovy) in active ingredient, strength, dosage form, route of administration, and expected performance.
Compounded semaglutide vs generic semaglutide comparison
| Category | Compounded semaglutide | Generic semaglutide |
|---|---|---|
| Approval status | Not FDA-approved | Approved by a regulator where authorized, such as Health Canada in Canada |
| US availability | Access has become more restricted after FDA shortage resolution | US residents can access generic semaglutide through BuyCanadianInsulin.com |
| Quality review | Not reviewed by the FDA before dispensing | Reviewed under generic drug approval standards in the approving country |
| Prescription required | Yes, if obtained legally | Yes |
| Main concern | Dosing errors, inconsistent concentrations, salt forms, quality uncertainty | Must verify country approval, indication, prescription, and pharmacy legitimacy |
| Best for | Patients with a specific medical need that approved products cannot meet | Patients who qualify for a regulator-approved lower-cost semaglutide option |
Is compounded semaglutide FDA approved?
No. Compounded semaglutide is not FDA-approved. The FDA does not review compounded semaglutide products for safety, effectiveness, manufacturing quality, dose accuracy, or whether they work the same way as Ozempic or Wegovy.
Some patients have turned to compounded GLP-1 products for weight loss. Since then, the agency has received multiple reports of severe adverse events, some requiring hospitalization. These included patients accidentally injecting five to 20 times the intended dose because they were unfamiliar with syringe measurements.
Not every compounding pharmacy is unsafe. A compounded drug may be appropriate for a specific patient based on a valid prescription. But it should not be treated as identical to FDA-approved Ozempic, Wegovy, or a regulator-approved generic.
Is generic semaglutide available in the US?
No. A fully FDA-approved generic Ozempic for US marketing is not yet available. Apotex announced on April 10, 2026, that it received tentative FDA approval for a generic version of Ozempic, but tentative approval does not allow the product to be marketed in the US until final approval requirements are met.
Many websites use phrases like “generic Ozempic” loosely. In the US, a product should not be described as an FDA-approved generic Ozempic unless the FDA has given final approval and the product is legally marketed.
For now, US patients typically have these legitimate semaglutide pathways:
-
- Ozempic, FDA-approved semaglutide injection for type 2 diabetes
-
- Wegovy, FDA-approved semaglutide for chronic weight management and certain cardiovascular risk reduction uses
-
- Rybelsus, FDA-approved oral semaglutide for type 2 diabetes
-
- Imported or Canadian pharmacy options, when handled through a legitimate pharmacy process and valid prescription
-
- Compounded semaglutide, only when clinically appropriate and legally prescribed, with added caution
Is generic semaglutide available in Canada?
Yes. Health Canada has authorized three generic semaglutide injection products so far. They first approved two generic semaglutide injections that are generic versions of Ozempic for type 2 diabetes. Then, approved Sevmia from Apotex, the first generic version of Wegovy for weight management.
Health Canada is also continuing to review more generic semaglutide submissions. As of this writing, six other generic semaglutide submissions are still under review, with more decisions expected in the coming weeks and months.
Authorized generic semaglutide products in Canada
| Approval order | Date approved | Company | Generic version of | Main indication |
|---|---|---|---|---|
| 1st | April 28, 2026 | Dr. Reddy’s Laboratories | Ozempic | Adults with type 2 diabetes |
| 2nd | May 1, 2026 | Apotex | Ozempic | Adults with type 2 diabetes |
| 3rd | June 29, 2026 | Apotex | Wegovy | Patients 12 years and older for chronic weight management |
1. Dr. Reddy’s Generic Semaglutide Injection
Health Canada authorized the first generic semaglutide injection on April 28, 2026. The submission was filed by Dr. Reddy’s Laboratories and is a generic version of Ozempic. It is indicated for once-weekly treatment of adults with type 2 diabetes to manage blood sugar levels.
Health Canada stated that generic semaglutide products are complex synthetic products that are pharmaceutically equivalent to the brand-name biologic drug, and that its review ensures differences do not affect the drug’s safety, efficacy, or quality.
2. Apotex Generic Semaglutide Injection
Health Canada authorized the second generic semaglutide injection on May 1, 2026. This one was filed by Canadian-based Apotex and is also a generic version of Ozempic. Like the Dr. Reddy’s product, it is indicated for once-weekly treatment of adults with type 2 diabetes to manage blood sugar levels.
3. Apotex Sevmia Generic Semaglutide Injection
On June 29, 2026, Health Canada authorized Sevmia, filed by Apotex, as the first generic semaglutide injection for weight loss in Canada. Health Canada states that Sevmia is a generic version of Wegovy.
Sevmia is indicated for once-weekly treatment of patients 12 years and older, as an add-on to a reduced-calorie diet and increased physical activity, for chronic weight management.
Does generic semaglutide work as well as Ozempic?
Yes. Generic semaglutide approved by Health Canada is expected to work similarly to Ozempic because it is pharmaceutically equivalent to the brand-name drug.
Health Canada reviews generic semaglutide products to make sure any differences do not affect the medication’s safety, effectiveness, or quality. That means an approved generic version should provide comparable results for eligible patients when used correctly and prescribed at the right dose.
However, results can still vary from person to person. Your response may depend on your dose, how consistently you use the medication, your diet, activity level, side effects, other medications, and whether you are switching after a treatment gap.
Which option is safer, compounded or generic semaglutide?
Generic semaglutide is generally the safer option, as long as it comes from a legitimate pharmacy and is used with a valid prescription.
For Canada specifically, Health Canada reviews generic drugs to make sure any differences from the brand-name drug do not affect safety, efficacy, or quality. Health Canada also continues monitoring approved products after authorization.
Compounded semaglutide is riskier because it does not go through the same premarket review. As of May 31, 2026, the FDA had received 990 adverse event reports involving compounded semaglutide and more than 730 involving compounded tirzepatide.
In 2024, the American Diabetes Association also recommended against using non-FDA-approved compounded GLP-1 or dual GIP/GLP-1 products.
A major concern is that compounded versions may not be equivalent to approved drugs. They may use different salt forms, excipients, delivery systems, concentrations, or added ingredients, which can affect how the drug is absorbed, distributed, and cleared from the body.
Some compounders add ingredients such as vitamin B12, vitamin B6, L-carnitine, or NAD, but the safety and effectiveness of combining these with semaglutide have not been established.
Some pharmacies also use semaglutide sodium or semaglutide acetate, which are different from the base form of semaglutide used in approved medications. The FDA recommends against using salt forms to compound semaglutide.
Dosing is another issue. Compounded products may have nonstandard labels, different concentrations, or syringe-based dosing, which can lead to dosing mistakes.
Which option is cheaper?
Compounded semaglutide may cost less, with some telehealth offers ranging from $129 to $149/month. Other price guides list around $179 to $499/month, while other sources show lower entry prices of less than $100/month.
On the other hand, generic semaglutide from Canada costs $199.99/month or per pen.
Compounded semaglutide has often been marketed as a lower-cost alternative. However, it can come with added questions about source and whether the product uses the same active ingredient as approved drugs.
Why is compounded semaglutide so much cheaper?
Compounded semaglutide is often cheaper because compounders are not paying for the same approval pathway, clinical data package, product labeling review, device testing, and manufacturing review that approved drugs go through.
Most compounded versions are also dispensed in vials with syringes, which can lower packaging costs compared with prefilled pens. It also avoids insurance and pharmacy benefit manager pricing since it is often sold directly to patients through monthly subscriptions.
What should you avoid when comparing lower-cost semaglutide options?
Avoid any seller that promises semaglutide without a prescription, refuses to identify the pharmacy, or uses vague wording like “GLP-1 blend.” Legitimate semaglutide access should involve a licensed prescriber, a licensed pharmacy, and clear product labeling.
Avoid these red flags:
-
- No prescription required
- “Research peptide” language
- No pharmacy license shown
- No clear manufacturer
- No clear active ingredient form
- No dose in milligrams
- No pharmacist contact information
- Claims that it is “FDA-approved compounded semaglutide”
- Claims that compounded semaglutide is the same as generic semaglutide
- Prices that seem too good to be true
Is compounded semaglutide still allowed?
Yes, but in a much more limited way than before. The FDA’s enforcement discretion period for 503A state-licensed pharmacies and physicians ended on April 22, 2025. For 503B outsourcing facilities, it ended on May 22, 2025. That means compounders can no longer make routine “copy” versions of semaglutide just because the brand-name drug was hard to find.
Compounded semaglutide is not completely banned. Traditional compounding of semaglutide is still allowed, but only when there is a specific medical need for an individual patient, such as a documented reason the patient cannot use an available approved product.
Mass-marketed, copycat compounded semaglutide is no longer allowed.
Can you switch from compounded semaglutide to generic semaglutide?
Yes, you may be able to switch from compounded semaglutide to generic semaglutide, but you should do it with medical guidance.
Here is a step-by-step way to approach the switch.
Step 1. Tell your doctor exactly what compounded product you are using
Before switching, your doctor needs to know what you are currently taking. Bring the medication label, vial, prescription details, or pharmacy instructions if you have them.
Try to confirm:
-
- The stated ingredient
- The concentration, such as mg/mL
- Your current dose
- How many units you inject
- How often you inject
- Whether it contains added ingredients, such as vitamin B12, B6, L-carnitine, or NAD
- Where you received it, such as a compounding pharmacy, telehealth clinic, med spa, or wellness center
Step 2. Confirm whether generic semaglutide is appropriate for your condition
Ask your doctor whether the generic semaglutide product matches your treatment goal. Some generic semaglutide products are approved as Ozempic equivalents for type 2 diabetes, while others may be approved as Wegovy equivalents for chronic weight management.
This distinction matters because the dosing, indication, and treatment goals may be different. An Ozempic-equivalent generic should not automatically be treated as a Wegovy-equivalent product.
Step 3. Do not overlap compounded and generic semaglutide
Do not use compounded semaglutide and generic semaglutide at the same time. Taking both too close together may increase the risk of nausea, vomiting, diarrhea, constipation, dehydration, low blood sugar if you take diabetes medications, and other side effects.
Your doctor should tell you when to take your last compounded dose and when to start the generic version.
Step 4. Ask whether you should restart at a lower dose
You may not be able to move directly from your compounded dose to an equivalent-looking generic dose. This is especially true if your compounded product had unclear concentration, you missed doses, you had side effects, or you stopped treatment for several weeks.
Your doctor may recommend restarting lower and increasing gradually to reduce side effects. This can be safer than trying to match your old compounded dose too aggressively.
Step 5. Watch for side effects during the first few weeks
Side effects can change after switching. Even if you tolerated compounded semaglutide, you may still notice nausea, constipation, reflux, appetite changes, diarrhea, vomiting, or stomach discomfort after starting generic semaglutide.
Call your doctor if side effects are severe or if you have repeated vomiting, signs of dehydration, severe stomach pain, yellowing of the skin or eyes, fainting, or symptoms of low blood sugar.
Step 6. Monitor blood sugar if you have diabetes
If you have type 2 diabetes or take insulin, sulfonylureas, or other glucose-lowering medications, ask your doctor how often to check your blood sugar after switching. Your readings may change if your dose changes, your appetite drops, or your eating pattern changes.
Your doctor may adjust your diabetes medications to lower the risk of hypoglycemia.
Step 7. Schedule a follow-up visit
Do not treat the switch as a one-time prescription change. Ask when to follow up, what symptoms to track, and whether labs are needed. Your doctor may want to monitor your weight, appetite, side effects, blood sugar, A1C, kidney function, blood pressure, or other markers depending on your health history.
Step 8. Order from a legitimate pharmacy
Generic semaglutide should be obtained through a legitimate pharmacy that requires a valid prescription. Avoid any source that sells semaglutide without a prescription or does not clearly identify the product, manufacturer, dose, and dispensing pharmacy.
Frequently Asked Questions
Articles you may also be interested in
